1. Home
  2. VSTM vs NPFD Comparison

VSTM vs NPFD Comparison

Compare VSTM & NPFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • NPFD
  • Stock Information
  • Founded
  • VSTM 2010
  • NPFD 2021
  • Country
  • VSTM United States
  • NPFD United States
  • Employees
  • VSTM N/A
  • NPFD N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • NPFD Trusts Except Educational Religious and Charitable
  • Sector
  • VSTM Health Care
  • NPFD Finance
  • Exchange
  • VSTM Nasdaq
  • NPFD Nasdaq
  • Market Cap
  • VSTM 581.6M
  • NPFD 480.1M
  • IPO Year
  • VSTM 2012
  • NPFD N/A
  • Fundamental
  • Price
  • VSTM $8.00
  • NPFD $19.82
  • Analyst Decision
  • VSTM Strong Buy
  • NPFD
  • Analyst Count
  • VSTM 9
  • NPFD 0
  • Target Price
  • VSTM $13.38
  • NPFD N/A
  • AVG Volume (30 Days)
  • VSTM 2.9M
  • NPFD 64.7K
  • Earning Date
  • VSTM 11-04-2025
  • NPFD 01-01-0001
  • Dividend Yield
  • VSTM N/A
  • NPFD 6.28%
  • EPS Growth
  • VSTM N/A
  • NPFD N/A
  • EPS
  • VSTM N/A
  • NPFD N/A
  • Revenue
  • VSTM $13,379,000.00
  • NPFD N/A
  • Revenue This Year
  • VSTM $88.60
  • NPFD N/A
  • Revenue Next Year
  • VSTM $416.99
  • NPFD N/A
  • P/E Ratio
  • VSTM N/A
  • NPFD N/A
  • Revenue Growth
  • VSTM 33.79
  • NPFD N/A
  • 52 Week Low
  • VSTM $3.46
  • NPFD $14.50
  • 52 Week High
  • VSTM $11.25
  • NPFD $18.07
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 43.46
  • NPFD 49.57
  • Support Level
  • VSTM $7.55
  • NPFD $19.72
  • Resistance Level
  • VSTM $10.09
  • NPFD $20.03
  • Average True Range (ATR)
  • VSTM 0.64
  • NPFD 0.17
  • MACD
  • VSTM -0.09
  • NPFD -0.01
  • Stochastic Oscillator
  • VSTM 16.54
  • NPFD 47.14

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About NPFD Nuveen Variable Rate Preferred & Income Fund

Nuveen Variable Rate Preferred&Income is a diversified, closed-end management investment company. Its investment objective is to provide a high level of current income and total return. The fund invests a majority of its assets in variable-rate preferred securities and other variable-rate income-producing securities. The rest of its investments can be made in contingent capital securities or contingent convertible securities, convertible securities, corporate debt securities, U.S. government securities, residential and commercial mortgage-backed securities, fixed-rate preferred securities, senior loans and loan participations and assignments, sovereign debt instruments, debt securities issued by supranational agencies, and/or taxable and tax-exempt municipal bonds.

Share on Social Networks: